Patients with diabetes should have access to longer subsidised appointments with allied health professionals and greater access to GLP-1 receptor agonists, a parliamentary inquiry has…
An IMG has been suspended, along with two other doctors, after she was allowed to treat patients unsupervised while on provisional registration — even after…
When this GP received an AHPRA notification, two things stood out. It used the wrong practice address, and the GP had never treated the patient.…
New safety warnings about the risk of ileus have been added to all GLP-1 receptor agonists following a TGA investigation into local reports of the…
GP practices in NSW are being offered payroll tax relief provided they bulk-bill at least 70% of patient consults. The State Government says it will…
The rapid unravelling of the Chiropractic Board of Australia’s position on spinal manipulation in babies is about more than regulatory red faces. The board initially…
More than a year before the Federal Government announced its compounding ban, the pharmaceutical giant Novo Nordisk was making complaints to AHPRA about pharmacies compounding…
What sparked the Department of Health and Aged Care decision to change prescribing rules for type 2 diabetes medications on the PBS? The 1 June…
Doctors prescribing GLP-1 receptor agonists now require telephone or electronic authority when initiating therapy for all PBS indications. On 1 June, health officials tightened the…
An independent review of the AHPRA system will attempt to streamline the complaints process, including the involvement of tribunals, by culling “unproductive” and “unnecessary” parts…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
